Загрузка...

Role of erlotinib in the targeted treatment of non-small-cell lung cancer in Chinese patients

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have been demonstrated to improve responses and clinical outcomes significantly in patients with advanced non-small-cell lung cancer (NSCLC). In retrospective subgroup analyses of several studies, patients with Asian ethnicity...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Li, Wei, Zhou, Fei, Zhou, Caicun
Формат: Artigo
Язык:Inglês
Опубликовано: Dove Medical Press 2014
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3928465/
https://ncbi.nlm.nih.gov/pubmed/24611018
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S45096
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!